Preoperative Immunotherapy Could Enhance Breast Cancer Cure Rates
DALLAS – Feb. 04, 2025 – A phase three clinical trial co-led by a researcher at UT Southwestern Harold C. Simmons Comprehensive Cancer Center showcases the promise of administering immunotherapy along with chemotherapy before surgery in patients with …